pharma · Gastric Adenocarcinoma
Basilea Pharmaceutica
Basilea Pharmaceutica is a pharma organization headquartered in Allschwil, CH. Primary therapeutic focus areas include Gastric Adenocarcinoma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent r
Allschwil, CH HQ
2000 Founded
246 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Allschwil, CH
- Founded
- 2000
- Employees
- 246
- Programs
- 2
- Drugs
- 3
- Patents
- 25
Oral Fosmanogepix
Phase 1 · small molecule · Healthy
Oral Fosmanogepix for Healthy is a Phase 1 program (small_molecule) at Basilea Pharmaceutica with 1 ClinicalTrials.gov record(s).
Internal code FMGX-CP-109
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Basilea Pharmaceutica
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Healthy
- Status
- completed
- Trials
- 1